Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone.

Emanuele Cencini,Melania Rocco,Francesco Ghio,Federico Simonetti,Annarosa Cuccaro,Federica De Marco,Chiara Consoli,Monica Bocchia,Alberto Fabbri

European journal of haematology（2023）

引用 0|浏览1

暂无评分

摘要

In this real-life experience, pixantrone demonstrated long-term efficacy in a cohort of R/R DLBCL cases who had previously received at least two prior regimens; many of whom had characteristics associated with poor prognosis.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要